Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 263

1.

Noncontrast CT versus Perfusion-Based Core Estimation in Large Vessel Occlusion: The Blood Pressure after Endovascular Stroke Therapy Study.

Siegler JE, Messé SR, Sucharew H, Kasner SE, Mehta T, Arora N, Starosciak AK, De Los Rios La Rosa F, Barnhill NR, Mistry AM, Patel K, Assad S, Tarboosh A, Dakay K, Wagner J, Bennett A, Jagadeesan B, Streib C, Weber SA, Chitale R, Volpi JJ, Mayer SA, Yaghi S, Jayaraman MV, Khatri P, Mistry EA.

J Neuroimaging. 2019 Nov 24. doi: 10.1111/jon.12682. [Epub ahead of print]

PMID:
31762108
2.

Thrombectomy in DAWN- and DEFUSE-3-Ineligible Patients: A Subgroup Analysis From the BEST Prospective Cohort Study.

Siegler JE, Messé SR, Sucharew H, Kasner SE, Mehta T, Arora N, Starosciak AK, De Los Rios La Rosa F, Barnhill NR, Mistry AM, Patel K, Assad S, Tarboosh A, Dakay K, Salwi S, Wagner J, Bennett A, Jagadeesan BD, Streib C, Weber SA, Chitale R, Volpi JJ, Mayer SA, Yaghi S, Jayaraman M, Khatri P, Mistry EA.

Neurosurgery. 2019 Nov 23. pii: nyz485. doi: 10.1093/neuros/nyz485. [Epub ahead of print]

PMID:
31758197
3.

Qualitative Assessment and Reporting Quality of Intracranial Vessel Wall MR Imaging Studies: A Systematic Review.

Song JW, Guiry SC, Shou H, Wang S, Witschey WR, Messé SR, Kasner SE, Loevner LA.

AJNR Am J Neuroradiol. 2019 Dec;40(12):2025-2032. doi: 10.3174/ajnr.A6317. Epub 2019 Nov 14.

PMID:
31727743
4.

Regional, sex, and age differences in diagnostic testing among participants in the NAVIGATE-ESUS trial.

Arauz A, Serrano F, Pearce LA, Kasner SE, Ameriso SF, Toni D, Bereczki D, Siegler J, Ruiz-Franco A, Cantú-Brito C, Czlonkowska A, Lang W, Berkowitz SD, Mundl H, Hart RG.

Int J Stroke. 2019 Oct 20:1747493019884523. doi: 10.1177/1747493019884523. [Epub ahead of print]

PMID:
31631796
5.

Infarct Patterns in Patients with Atherosclerotic Vertebrobasilar Disease in Relation to Hemodynamics.

Schaafsma JD, Silver FL, Kasner SE, Caplan LR, Rose-Finnell L, Charbel FT, Pandey DK, Amin-Hanjani S; for the VERiTAS Study Group.

Cerebrovasc Dis Extra. 2019 Oct 16;9(3):123-128. doi: 10.1159/000503091. [Epub ahead of print]

6.

Blood Pressure after Endovascular Therapy for Ischemic Stroke (BEST): A Multicenter Prospective Cohort Study.

Mistry EA, Sucharew H, Mistry AM, Mehta T, Arora N, Starosciak AK, De Los Rios La Rosa F, Siegler JE 3rd, Barnhill NR, Patel K, Assad S, Tarboosh A, Dakay K, Salwi S, Cruz AS, Wagner J, Fortuny E, Bennett A, James RF, Jagadeesan B, Streib C, O'Phelan K, Kasner SE, Weber SA, Chitale R, Volpi JJ, Mayer S, Yaghi S, Jayaraman MV, Khatri P.

Stroke. 2019 Dec;50(12):3449-3455. doi: 10.1161/STROKEAHA.119.026889. Epub 2019 Oct 7.

PMID:
31587660
7.

Poor concordance among drug compendia for proposed interactions between enzyme-inducing antiepileptic drugs and direct oral anticoagulants.

Acton EK, Willis AW, Gelfand MA, Kasner SE.

Pharmacoepidemiol Drug Saf. 2019 Nov;28(11):1534-1538. doi: 10.1002/pds.4896. Epub 2019 Sep 13.

PMID:
31517414
8.

Cerebral Blood Flow Response During Bolus Normal Saline Infusion After Ischemic Stroke.

Mullen MT, Parthasarathy AB, Zandieh A, Baker WB, Mesquita RC, Loomis C, Torres J, Guo W, Favilla CG, Messé SR, Yodh AG, Detre JA, Kasner SE.

J Stroke Cerebrovasc Dis. 2019 Nov;28(11):104294. doi: 10.1016/j.jstrokecerebrovasdis.2019.07.010. Epub 2019 Aug 13.

PMID:
31416759
9.

Disability after minor stroke and TIA: A secondary analysis of the SOCRATES trial.

Cucchiara B, George DK, Kasner SE, Knutsson M, Denison H, Ladenvall P, Amarenco P, Johnston SC.

Neurology. 2019 Aug 13;93(7):e708-e716. doi: 10.1212/WNL.0000000000007936. Epub 2019 Jul 11.

PMID:
31296654
10.

Expanding Eligibility in Stroke Prevention Trials to Patients with Early Disability.

Kasner SE, Siegler JE, Zamzam A, Kleindorfer D; VISTA-Acute Collaborators.

J Stroke Cerebrovasc Dis. 2019 Aug;28(8):2268-2272. doi: 10.1016/j.jstrokecerebrovasdis.2019.05.016. Epub 2019 May 31.

PMID:
31160220
11.

Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial.

Hart RG, Veltkamp RC, Sheridan P, Sharma M, Kasner SE, Bangdiwala SI, Ntaios G, Shoamanesh A, Ameriso SF, Toni D, Czlonkowska A, Lindgren A, Hankey GJ, Perera KS, Shuaib A, Coutts SB, Gagliardi RJ, Berkowitz SD, Mundl H, Peters G, Connolly SJ; NAVIGATE ESUS Investigators.

J Stroke Cerebrovasc Dis. 2019 Aug;28(8):2273-2279. doi: 10.1016/j.jstrokecerebrovasdis.2019.05.014. Epub 2019 May 31.

PMID:
31160218
12.

Perfusion Enhancement with Respiratory Impedance After Stroke (PERI-Stroke).

Favilla CG, Forti RM, Zamzam A, Detre JA, Mullen MT, Yodh AG, Kasner SE, Busch DR, Baker WB, Mesquita RC, Kung D, Messé SR.

Neurotherapeutics. 2019 May 28. doi: 10.1007/s13311-019-00744-1. [Epub ahead of print]

PMID:
31140115
13.

Cost-effectiveness of percutaneous closure of a patent foramen ovale compared with medical management in patients with a cryptogenic stroke: from the US payer perspective.

Volpi JJ, Ridge JR, Nakum M, Rhodes JF, Søndergaard L, Kasner SE.

J Med Econ. 2019 Sep;22(9):883-890. doi: 10.1080/13696998.2019.1611587. Epub 2019 May 17.

PMID:
31025589
14.

Transcranial Optical Monitoring of Cerebral Hemodynamics in Acute Stroke Patients during Mechanical Thrombectomy.

Forti RM, Favilla CG, Cochran JM, Baker WB, Detre JA, Kasner SE, Mullen MT, Messé SR, Kofke WA, Balu R, Kung D, Pukenas BA, Sedora-Roman NI, Hurst RW, Choudhri OA, Mesquita RC, Yodh AG.

J Stroke Cerebrovasc Dis. 2019 Jun;28(6):1483-1494. doi: 10.1016/j.jstrokecerebrovasdis.2019.03.019. Epub 2019 Apr 8.

PMID:
30975462
15.

Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical Trial.

Healey JS, Gladstone DJ, Swaminathan B, Eckstein J, Mundl H, Epstein AE, Haeusler KG, Mikulik R, Kasner SE, Toni D, Arauz A, Ntaios G, Hankey GJ, Perera K, Pagola J, Shuaib A, Lutsep H, Yang X, Uchiyama S, Endres M, Coutts SB, Karlinski M, Czlonkowska A, Molina CA, Santo G, Berkowitz SD, Hart RG, Connolly SJ.

JAMA Neurol. 2019 Jul 1;76(7):764-773. doi: 10.1001/jamaneurol.2019.0617.

PMID:
30958508
16.

Cerebrospinal Fluid in Posterior Reversible Encephalopathy Syndrome: Implications of Elevated Protein and Pleocytosis.

Ellis CA, McClelland AC, Mohan S, Kuo E, Kasner SE, Zhang C, Khankhanian P, Balu R.

Neurohospitalist. 2019 Apr;9(2):58-64. doi: 10.1177/1941874418802061. Epub 2018 Sep 27.

PMID:
30915182
17.

Hypoperfusion Symptoms Poorly Predict Hemodynamic Compromise and Stroke Risk in Vertebrobasilar Disease.

Amin-Hanjani S, Stapleton CJ, Du X, Rose-Finnell L, Pandey DK, Elkind MSV, Zipfel GJ, Liebeskind DS, Silver FL, Kasner SE, Caplan LR, Derdeyn CP, Gorelick PB, Charbel FT; VERiTAS Study Group.

Stroke. 2019 Feb;50(2):495-497. doi: 10.1161/STROKEAHA.118.023101.

PMID:
30580717
18.

Association Between Anxiety, Depression, and Post-traumatic Stress Disorder and Outcomes After Ischemic Stroke.

Stein LA, Goldmann E, Zamzam A, Luciano JM, Messé SR, Cucchiara BL, Kasner SE, Mullen MT.

Front Neurol. 2018 Nov 2;9:890. doi: 10.3389/fneur.2018.00890. eCollection 2018.

19.

Characterization of Recurrent Strokes With and Without Patent Foramen Ovale Closure.

Kasner SE, Kase CS, Turan TN, Rowley HA, Andersen G, Iversen HK, Roine RO, Messé SR, Volpi J, Søndergaard L, Rhodes JF, Sjöstrand C; REDUCE Study Investigators.

J Am Coll Cardiol. 2018 Nov 13;72(20):2542-2544. doi: 10.1016/j.jacc.2018.08.2175. No abstract available.

20.

Evaluating the cost-effectiveness of percutaneous closure of a patent foramen ovale versus medical management in patients with a cryptogenic stroke: from the UK payer perspective.

Hildick-Smith D, Turner M, Shaw L, Nakum M, Hartaigh BÓ, Evans RM, Rhodes JF, Sondergaard L, Kasner SE.

J Med Econ. 2019 Feb;22(2):131-139. doi: 10.1080/13696998.2018.1548355. Epub 2018 Nov 29.

PMID:
30424680
21.

Cognition and Cerebral Infarction in Older Adults After Surgical Aortic Valve Replacement.

Giovannetti T, Price CC, Fanning M, Messé S, Ratcliffe SJ, Lyon A, Kasner SE, Seidel G, Bavaria JE, Szeto WY, Hargrove WC 3rd, Acker MA, Floyd TF; DENOVO Investigators.

Ann Thorac Surg. 2019 Mar;107(3):787-794. doi: 10.1016/j.athoracsur.2018.09.057. Epub 2018 Nov 10.

PMID:
30423336
22.

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.

Kasner SE, Swaminathan B, Lavados P, Sharma M, Muir K, Veltkamp R, Ameriso SF, Endres M, Lutsep H, Messé SR, Spence JD, Nedeltechev K, Perera K, Santo G, Olavarria V, Lindgren A, Bangdiwala S, Shoamanesh A, Berkowitz SD, Mundl H, Connolly SJ, Hart RG; NAVIGATE ESUS Investigators.

Lancet Neurol. 2018 Dec;17(12):1053-1060. doi: 10.1016/S1474-4422(18)30319-3. Epub 2018 Sep 28. Erratum in: Lancet Neurol. 2018 Oct 23;:.

23.

CCL2 and CXCL10 are associated with poor outcome after intracerebral hemorrhage.

Landreneau MJ, Mullen MT, Messé SR, Cucchiara B, Sheth KN, McCullough LD, Kasner SE, Sansing LH; Serum Markers After Spontaneous Cerebral Hemorrhage (SMASCH) Investigators.

Ann Clin Transl Neurol. 2018 Jul 3;5(8):962-970. doi: 10.1002/acn3.595. eCollection 2018 Aug.

24.

Patent foramen ovale and cryptogenic stroke: diagnosis and updates in secondary stroke prevention.

Yuan K, Kasner SE.

Stroke Vasc Neurol. 2018 Jun 26;3(2):84-91. doi: 10.1136/svn-2018-000173. eCollection 2018 Jun. Review.

25.

Correction: Nonsteroidal anti-inflammatory drug choice and adverse outcomes in clopidogrel users: A retrospective cohort study.

Nam YH, Brensinger CM, Bilker WB, Leonard CE, Kasner SE, Grosser T, Li X, Hennessy S.

PLoS One. 2018 Jul 16;13(7):e0200982. doi: 10.1371/journal.pone.0200982. eCollection 2018.

26.

To Treat or Not to Treat?

Levine SR, Weingast SZ, Weedon J, Stefanov DG, Katz P, Hurley D, Kasner SE, Khatri P, Broderick JP, Grotta JC, Feldmann E, Panagos PD, Romano JG, Bianchi R, Meyer BC, Scott PA, Kim D, Balucani C.

Stroke. 2018 Aug;49(8):1933-1938. doi: 10.1161/STROKEAHA.118.020971.

PMID:
29976582
27.

Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES Trial.

Wong KSL, Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Himmelmann A, Kasner SE, Knutsson M, Ladenvall P, Minematsu K, Molina CA, Wang Y, Johnston SC; SOCRATES Steering Committee and Investigators.

Stroke. 2018 Jul;49(7):1678-1685. doi: 10.1161/STROKEAHA.118.020553. Epub 2018 Jun 18.

28.

Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.

Hart RG, Sharma M, Mundl H, Kasner SE, Bangdiwala SI, Berkowitz SD, Swaminathan B, Lavados P, Wang Y, Wang Y, Davalos A, Shamalov N, Mikulik R, Cunha L, Lindgren A, Arauz A, Lang W, Czlonkowska A, Eckstein J, Gagliardi RJ, Amarenco P, Ameriso SF, Tatlisumak T, Veltkamp R, Hankey GJ, Toni D, Bereczki D, Uchiyama S, Ntaios G, Yoon BW, Brouns R, Endres M, Muir KW, Bornstein N, Ozturk S, O'Donnell MJ, De Vries Basson MM, Pare G, Pater C, Kirsch B, Sheridan P, Peters G, Weitz JI, Peacock WF, Shoamanesh A, Benavente OR, Joyner C, Themeles E, Connolly SJ; NAVIGATE ESUS Investigators.

N Engl J Med. 2018 Jun 7;378(23):2191-2201. doi: 10.1056/NEJMoa1802686. Epub 2018 May 16.

29.

Protocol for promoting recovery optimization of walking activity in stroke (PROWALKS): a randomized controlled trial.

Wright H, Wright T, Pohlig RT, Kasner SE, Raser-Schramm J, Reisman D.

BMC Neurol. 2018 Apr 12;18(1):39. doi: 10.1186/s12883-018-1044-1.

30.

Nonsteroidal anti-inflammatory drug choice and adverse outcomes in clopidogrel users: A retrospective cohort study.

Nam YH, Brensinger CM, Bilker WB, Leonard CE, Kasner SE, Grosser T, Li X, Hennessy S.

PLoS One. 2018 Mar 14;13(3):e0193800. doi: 10.1371/journal.pone.0193800. eCollection 2018. Erratum in: PLoS One. 2018 Jul 16;13(7):e0200982.

31.

Basilar Artery Lateral Displacement May Be Associated with Migraine with Aura.

Zhang C, Detre JA, Kasner SE, Cucchiara B.

Front Neurol. 2018 Feb 21;9:80. doi: 10.3389/fneur.2018.00080. eCollection 2018.

32.

Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial.

Kasner SE, Lavados P, Sharma M, Wang Y, Wang Y, Dávalos A, Shamalov N, Cunha L, Lindgren A, Mikulik R, Arauz A, Lang W, Czlonkowska A, Eckstein J, Gagliardi R, Amarenco P, Ameriso SF, Tatlisumak T, Veltkamp R, Hankey GJ, Toni DS, Bereczki D, Uchiyama S, Ntaios G, Yoon BW, Brouns R, DeVries Basson MM, Endres M, Muir K, Bornstein N, Ozturk S, O'Donnell M, Mundl H, Pater C, Weitz J, Peacock WF, Swaminathan B, Kirsch B, Berkowitz SD, Peters G, Pare G, Themeles E, Shoamanesh A, Connolly SJ, Hart RG; NAVIGATE ESUS Steering Committee and Investigators.

J Stroke Cerebrovasc Dis. 2018 Jun;27(6):1673-1682. doi: 10.1016/j.jstrokecerebrovasdis.2018.01.027. Epub 2018 Mar 7.

33.

Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Turakhia MP, Blankestijn PJ, Carrero JJ, Clase CM, Deo R, Herzog CA, Kasner SE, Passman RS, Pecoits-Filho R, Reinecke H, Shroff GR, Zareba W, Cheung M, Wheeler DC, Winkelmayer WC, Wanner C; Conference Participants.

Eur Heart J. 2018 Jun 21;39(24):2314-2325. doi: 10.1093/eurheartj/ehy060. No abstract available.

34.

Nontraumatic intracerebral haemorrhage in young adults.

Tatlisumak T, Cucchiara B, Kuroda S, Kasner SE, Putaala J.

Nat Rev Neurol. 2018 Apr;14(4):237-250. doi: 10.1038/nrneurol.2018.17. Epub 2018 Mar 9. Review.

PMID:
29521335
35.

Is Patent Foramen Ovale a Risk Factor for Perioperative Stroke?

Kasner SE, Messe SR.

JAMA. 2018 Feb 6;319(5):446-447. doi: 10.1001/jama.2017.21902. No abstract available.

PMID:
29411017
36.

Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging.

Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, McTaggart RA, Torbey MT, Kim-Tenser M, Leslie-Mazwi T, Sarraj A, Kasner SE, Ansari SA, Yeatts SD, Hamilton S, Mlynash M, Heit JJ, Zaharchuk G, Kim S, Carrozzella J, Palesch YY, Demchuk AM, Bammer R, Lavori PW, Broderick JP, Lansberg MG; DEFUSE 3 Investigators.

N Engl J Med. 2018 Feb 22;378(8):708-718. doi: 10.1056/NEJMoa1713973. Epub 2018 Jan 24.

37.

Trials of Patent Foramen Ovale Closure.

Kasner SE, Søndergaard L; Gore REDUCE Clinical Study Investigators.

N Engl J Med. 2017 Dec 28;377(26):2600-2601. doi: 10.1056/NEJMc1714320. No abstract available.

PMID:
29300446
38.

Dynamic autoregulation of cerebral blood flow measured non-invasively with fast diffuse correlation spectroscopy.

Parthasarathy AB, Gannon KP, Baker WB, Favilla CG, Balu R, Kasner SE, Yodh AG, Detre JA, Mullen MT.

J Cereb Blood Flow Metab. 2018 Feb;38(2):230-240. doi: 10.1177/0271678X17747833. Epub 2017 Dec 12.

39.

Recanalization after Extracranial Dissection: Effect of Antiplatelet Compared with Anticoagulant Therapy.

Ramchand P, Mullen MT, Bress A, Hurst R, Kasner SE, Cucchiara BL, Messé SR.

J Stroke Cerebrovasc Dis. 2018 Feb;27(2):438-444. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.065. Epub 2017 Oct 31.

PMID:
29100856
40.
41.

Pioglitazone Prevents Stroke in Patients With a Recent Transient Ischemic Attack or Ischemic Stroke: A Planned Secondary Analysis of the IRIS Trial (Insulin Resistance Intervention After Stroke).

Yaghi S, Furie KL, Viscoli CM, Kamel H, Gorman M, Dearborn J, Young LH, Inzucchi SE, Lovejoy AM, Kasner SE, Conwit R, Kernan WN; IRIS Trial Investigators.

Circulation. 2018 Jan 30;137(5):455-463. doi: 10.1161/CIRCULATIONAHA.117.030458. Epub 2017 Oct 30.

PMID:
29084736
42.

Sex Differences in rt-PA Utilization at Hospitals Treating Stroke: The National Inpatient Sample.

Boehme AK, Carr BG, Kasner SE, Albright KC, Kallan MJ, Elkind MSV, Branas CC, Mullen MT.

Front Neurol. 2017 Sep 27;8:500. doi: 10.3389/fneur.2017.00500. eCollection 2017.

43.

Preventing Early Bouncebacks to the Neurointensive Care Unit: A Retrospective Analysis and Quality Improvement Pilot.

Coughlin DG, Kumar MA, Patel NN, Hoffman RL, Kasner SE.

Neurocrit Care. 2018 Apr;28(2):175-183. doi: 10.1007/s12028-017-0446-z.

PMID:
28929392
44.

Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.

Søndergaard L, Kasner SE, Rhodes JF, Andersen G, Iversen HK, Nielsen-Kudsk JE, Settergren M, Sjöstrand C, Roine RO, Hildick-Smith D, Spence JD, Thomassen L; Gore REDUCE Clinical Study Investigators.

N Engl J Med. 2017 Sep 14;377(11):1033-1042. doi: 10.1056/NEJMoa1707404.

45.

What Makes New Ischemic Lesions Symptomatic after Aortic Valve Replacement?

Leker RR, Messé SR, Erus G, Bilello M, Fanning M, Acker M, Massaro A, Kasner SE, Floyd T.

J Stroke Cerebrovasc Dis. 2017 Dec;26(12):2943-2948. doi: 10.1016/j.jstrokecerebrovasdis.2017.07.036. Epub 2017 Aug 24.

PMID:
28844834
46.

Interprovider Communication Using a Scheduled Provider Alert-Response Communication System in 3 Inpatient Neurology Units.

Siegler JE, Finegan D, Kasner SE, Price RS.

J Neurosci Nurs. 2017 Oct;49(5):258-263. doi: 10.1097/JNN.0000000000000312.

PMID:
28817503
47.

Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined Source.

Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Hill MD, Jonasson J, Kasner SE, Ladenvall P, Minematsu K, Molina CA, Wang Y, Wong KSL, Johnston SC; SOCRATES Steering Committee and Investigators.

Stroke. 2017 Sep;48(9):2480-2487. doi: 10.1161/STROKEAHA.117.017217. Epub 2017 Jul 18.

PMID:
28720658
48.

Non-Invasive Respiratory Impedance Enhances Cerebral Perfusion in Healthy Adults.

Favilla CG, Parthasarathy AB, Detre JA, Yodh AG, Mullen MT, Kasner SE, Gannon K, Messé SR.

Front Neurol. 2017 Feb 16;8:45. doi: 10.3389/fneur.2017.00045. eCollection 2017.

49.

Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial.

Amarenco P, Albers GW, Denison H, Easton JD, Evans SR, Held P, Hill MD, Jonasson J, Kasner SE, Ladenvall P, Minematsu K, Molina CA, Wang Y, Wong KSL, Johnston SC; SOCRATES Steering Committee and Investigators.

Lancet Neurol. 2017 Apr;16(4):301-310. doi: 10.1016/S1474-4422(17)30038-8. Epub 2017 Feb 23.

PMID:
28238711
50.

Plasma ADAMTS13 activity and von Willebrand factor antigen and activity in patients with subarachnoid haemorrhage.

Kumar M, Cao W, McDaniel JK, Pham HP, Raju D, Nawalinski K, Frangos S, Kung D, Zager E, Kasner SE, Levine JM, Zheng XL.

Thromb Haemost. 2017 Apr 3;117(4):691-699. doi: 10.1160/TH16-11-0834. Epub 2017 Jan 19.

Supplemental Content

Loading ...
Support Center